Close Menu
  • FDA
  • Categories
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Breast
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • Gastrointestinal
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Kidney
    • Liver
    • Lung
    • Lymphoma
    • Melanoma and Skin
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Prostate
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • MOASC
    • Upcoming Oncology Conferences
  • About
  • Contact
  • Advertise
Advertisement
X (Twitter) LinkedIn Facebook
X (Twitter) LinkedIn Facebook YouTube
OncologyTube
  • FDA
  • Categories
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Breast
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • Gastrointestinal
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Kidney
    • Liver
    • Lung
    • Lymphoma
    • Melanoma and Skin
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Prostate
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • MOASC
    • Upcoming Oncology Conferences
  • About
  • Contact
  • Advertise
Subscribe
OncologyTube
Home » Follicular lymphoma treatment journey from a patient’s perspective
Acute Lymphoblastic Leukemia

Follicular lymphoma treatment journey from a patient’s perspective

EditorBy EditorDecember 7, 2016No Comments1 Min Read
Twitter LinkedIn Facebook Email
Share
Twitter LinkedIn Facebook Email

Ian Hewson, BDSc, FICD, FADI, FPFA of Alfred Hospital, Melbourne, Australia talks about his treatment journey after being diagnosed with low grade follicular lymphoma (FL). Side effects from 6 cycles of CHOP treatment included peripheral neuropathy and overall feeling of being unwell. Dr Hewson mentions that sometimes it is better not to treat until disease progression, as treatments are associated with side effects like losing hair. A discussion with a clinician about wait and watch is recommended to address any doubts. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Ocular Oncology (ISOO) 2016 Annual Meeting on Supportive Care in Cancer held in Adelaide, Australia.

Follow on X (Twitter) Follow on LinkedIn Follow on Facebook Follow on Google News
Share. Twitter LinkedIn Facebook Email

Related Posts

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Acute Lymphoblastic Leukemia 3 Mins Read

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

Acute Lymphoblastic Leukemia 4 Mins Read

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Acute Lymphoblastic Leukemia 3 Mins Read
Recent Posts
  • Genitourinary Cancer [2025] Treatment Breakthroughs: ASCO GU 2025 Highlights Nataliya Mar, MD – MOASC
  • ICI-Induced Myocarditis: When Chest Pain Isn’t What It Seems
  • Sarcoma Updates [2025] The Role of Next-Generation Sequencing (NGS) in Treatment: Insights and Advances – Neil Chawla, MD
  • Lung Cancer [2025] Updates in Treatment & Staging: AACR 9th Edition and Beyond
  • Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber
Connect With Us on Social
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
Donate
X (Twitter) LinkedIn Facebook YouTube
  • FDA
  • Categories
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Breast
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • Gastrointestinal
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Kidney
    • Liver
    • Lung
    • Lymphoma
    • Melanoma and Skin
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Prostate
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • MOASC
    • Upcoming Oncology Conferences
  • About
  • Contact
  • Advertise
© 2025 Copyright Protected Medicus Networks, Inc. Privacy Policy

Type above and press Enter to search. Press Esc to cancel.

Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by online advertisements. Please support us by disabling your Ad Blocker.